Government FCPA Enforcement “Intensely Focused” on Life Sciences Companies

more+
less-

On November 12, 2009, Lanny Breuer, Assistant Attorney General for the Criminal Division of the Department of Justice, warned that in the “months and years ahead,” the Department of Justice will focus on “the application of the Foreign Corrupt Practices Act (or "FCPA?) to the pharmaceutical industry.” Previous FCPA enforcement actions also have focused on medical device companies. Given this DOJ initiative, life sciences companies should actively review and reinvigorate their FCPA compliance efforts.

Please see full update below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Published In: General Business Updates, Criminal Law Updates, Science, Computers & Technology Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Morrison & Foerster LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »